GAITHERSBURG, Maryland – One of the things that Emphasys (Redwood City, California) had going for it at an FDA advisory panel last Friday was that it presented a first-of-a-kind device, the Zephyr endobronchial valve system, which is designed to deal with a poorly met need, namely grade III and IV emphysema. (Medical Device Daily)